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CASE REPORT
A 54-year old Caucasian woman was admitted to hos-
pital because of severe acute pulmonary edema. She had
a 20-year history of hypertension, but recently all med-
ications were discontinued because of an episode of
syncope and a finding of very low arterial pressure (95/60
mmHg in the right arm). She complained of previously
formless symptoms, such as malaise, weakness, fatigue
and fever. Symptoms had presented occasionally since
she was 35-years old. A relapse of these symptoms oc-
curred 2 weeks before admission. 
At  physical  examination there  was  a  remarkable
blood pressure discrepancy between the right and left
arms. Blood pressure was undetectable in the left arm,
but was 95/60 mm Hg supine in the right arm. Both the
left radial and left brachial pulses wereimpalpable. Oth-
er significant findings include the following. She had a
heart rate of 100 beats per minute, and a body temper-
ature of 37.9°C. There was an III/IV systolic murmur
along the right sternal border and a diastolic blowing
murmur over the left. Chest auscultation revealed rales
and rhonchi, bilaterally. Subsequent chest radiography
demonstrated bilateral infiltrates and a modest bulge on
the third arch of the left heart border. T wave inversions
from  V2  to  V6  were  seen  at  ECG.  Trans-thoracic
echocardiography was, therefore, performed and docu-
mented a mild aortic regurgitation, and inferior and lat-
eral wall motion abnormality. The moderately low ejec-
tion fraction (50%) could not explain the severe clinical
picture. Positive laboratory findings included elevated
erythrocyte sedimentation rate (45 mm/1st h) and C-re-
active protein levels (5.3 mg/dL). Blood cultures, vene-
real disease research laboratory test, and autoimmune
serological findings were negative. Left and right heart
catheterizations  were  performed  through  the  right
femoralapproach. Recording of systolic aortic pressure
showed values up to 250 mmHg. The left and right sub-
clavian arteries were occluded and there was moderate
pulmonary hypertension (pressure 66 mmHg systolic).
The other angiographic findings were as follows: focal
narrowings of the abdominal and thoracic aorta as well
as severe calcification in the whole aorta; ostial occlu-
sion of the right coronary artery and severe stenosis of
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the first (90% stenosis) marginal obtuse. Two stents in
the marginal obtuse were successfully placed (residual
stenosis <20%). She was treated with oral methylpred-
nisone (40 mg/day), cloptidogrel, and diuretics (furosemide
25 mg/day). Inflammatory parameters normalized within 
3-weeks. She was discharged from hospital. Methyl-
prednisone was gradually reduced at a maintenance
dosage of 12 mg/day. She remained free of symptoms.
At 6 month follow-up the patient was still asympto-
matic. 
DISCUSSION
Takayasu’s disease is a chronic inflammatory dis-
ease of large- and medium-sized arteries, involving the
aorta and its main branches, the pulmonary arteries,
and the coronary tree. Since the original report of
Takayasu’s disease in 1908 (1), the estimated world-
wide incidence is 2.6 cases per million per year, with
women more commonly affected than men. Peak on-
set is in individuals in their 30s. The disease has been
mainly studied in Japan but Western studies have also
been published (2-8). Cardiac features are present in up
to 40% of cases. Patients usually have no risk factors
for atherosclerosis and yet have atheromatous aorta,
suggesting the importance of inflammation in athero-
sclerosis (9).
Vascular changes lead to main complications, includ-
ing hypertension, most often due to renal artery steno-
sis or, more rarely, stenosis of the suprarenal aorta; aor-
tic insufficiency due to aortic valve involvement; pul-
monary hypertension, and aortic or arterial aneurysm
(10, 11). Cardiomyopathy, myocarditis, and pericarditis
have been also reported (10). Patients with pulmonary
arterities  may  develop  pneumonia,  interstitial  pul-
monary fibrosis, and alveolar damage (12). Other clini-
cal manifestations include vertebrobasilar ischemia,
carotid stenosis, and hypertensive encephalopathy.
(13). Takayasu’s disease has also been associated with
inflammatory bowel disease, glomerulonephritis, sys-
temic  lupus,  rheumatoid  arthritis,  and  ankylosing
spondylitis (14, 15). Less common associations have
been seen with sensorineural hearing loss (16). The
retinopathy originally described by Takayasu’s is seen in
only about one-quarter of patients and is usually asso-
ciated with carotid artery involvement (17). 
Causes and pathophysiology
The etiology of the disease remains unknown. Tuber-
culosis was proposed as a predisposing factor (11,  18,
19). Patients with Takayasu’s arteritis were found to
have higher immunoglobulin G (IgG), immunoglobulin M
(IgM), and immunoglobulin A (IgA) titers against the M
tuberculosis extract than control patients (20). Accord-
ingly, recent work reported the presence of CD3+ T cells
and IgG antibodies reactive to circulating antimycobac-
terial heat shock protein 65 (mHSP65) antibodies and to
its human homologue, hHSP60 (21). However, these da-
ta appear to be in contradiction with other observations.
In a series of 17 children, none had active tubercular le-
sions (22). Cutaneous hypersensitivity to tubercular
protein was seen in only 35.2% of cases (22). Various
other mechanisms such as autoimmunity and genetic
predisposition have been proposed (23). Both cellular
and humoral factors are probably involved. Autoimmu-
nity appears to be the most plausible mechanism. De-
fective T lymphocyte regulation and anti-endothelial,
anticardiolipin, and antiaorta antibodies have been sug-
gested to play a role in the etiology of the disease (24-
26). The precise nature of the antigens needs to be
identified. 
Patient history and physical examination
Takayasu’s  arteritis  usually  progresses  through
stages. The first stage is an early systemic stage during
which the patient may complain of formless symptoms.
Fatigue, malaise, and fever are the most frequently en-
countered early symptoms. This stage is considered to
be prevasculitic. The second stage is concurrent with
the vascular inflammation. Symptoms characterizing
this stage include pain in extremities, dyspnea, palpita-
tions, headaches, rash (more often erythema nodosum),
hemoptysis, ulceration, and weight loss. Other symp-
toms may include arm numbness, claudication in the
legs, double vision, amaurosis fugax, stroke, transient
ischemic attacks, hemiplegia, and paraplegia. The third
step is the burned-out stage, when fibrosis sets in, and
is generally associated with remission of symptoms.
The formless systemic symptoms and vascular symp-
toms may occur at the same time.
A detailed careful physical examination, and appro-Takayasu’s arteritis
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priate laboratory tests are needed in all cases to deter-
mine the type of onset, course of illness, organ systems
affected, and extent of involvement. The main finding is
absent pulse(s) or a pulse discrepancy of greater than
10 mm Hg between the right and left arms. Other signifi-
cant signs include vascular bruits, focal neurologic
deficits,  hypertension,  retinal  ischemia  and  micro-
aneurysms, eclampsia, subarachnoid hemorrhage leg
edema, heart failure, and rarely, anginal symptoms. 
Laboratory tests 
Laboratory tests tend to be nonspecific. The ery-
throcyte sedimentation rate may be high, generally
greater than 50 mm/h, in early disease but it is often
paradoxically normal later. Leukocyte count may be
normal  or  slightly  elevated.  A  moderate,  nor-
mochromic anemia may be present in patients with
advanced disease. Autoantibodies observed in other
connective tissue diseases, including antinuclear an-
tibodies, rheumatoid factor, and antineutrophil cyto-
plasmic antibodies are as common as in the general
population. Hypoalbuminemia and increased levels of
fibrinogen, C reactive protein, and gamma globulin
are frequent findings. HLA typing has not confirmed
any definite association.
Imaging
Angiography is the criterion standard (11, 27, 28). An-
giographic criteria must show narrowing of the aorta, its
primary branches, or large arteries in the proximal upper
or lower extremities. Changes are usually focal or seg-
mental. Angiographic classification allows a compari-
son of patient characteristics according to the vessels
involved and is helpful in planning surgery,but they offer
little by way of prognosis (28). Computed tomography
(CT) scanning or ultrasound may be used to assess the
thickness of the aorta (29). Magnetic resonance (MR)
can be used to noninvasively assess the vasculature,
but it is less accurate (30). Ultrasonography, and gallium
as well as whole-body positron emission tomography
(PET) scanning may provide useful information to as-
sess the degree of inflammatory involvement of the ves-
sels (31-33). The additional value of these new tech-
niques in the diagnosis and follow-up of patients with
Takayasu’s arteritis needs further validation.
Diagnosis 
Diagnosis of Takayasu’s arteritis is often delayed or
even missed because this disease has a non-specific
clinical presentation. Ishikawa’s criteria (2) (Tab. I) and
those of the American College of Rheumatology (27)
are both reliable clinical tools (Tab. II). Given the het-
erogeneity of the disease depending upon geographic
location, it is not surprising that none of the criteria
have universal applicability. Hence, Sharma et al (34)
have proposed modifications as follows: (a) removal of
age less than 40 years; (b) inclusion of signs and
symptoms as a major criteria; (c) removal of age in the
definition of hypertension; (d) deletion of the absence
of aorto-iliac lesion in defining abdominal aortic lesion
and (e) in addition, inclusion of coronary artery lesion
in absence of risk factors. 
Treatment
Medical management depends on the disease ac-
tivity and the complications that are present. Some
patients have only mild forms of Takayasu’s arteritis;
others deteriorate considerably. The two most impor-
tant goals of treatment are controlling the inflammato-
ry process and controlling the hypertension. Corticos-
teroids are the most important therapeutic agents and
are necessary in active disease. Therapy is continued
until patients achieve remission. For patients who do
not achieve remission on corticosteroids, cytotoxic
agents such as methotrexate or cyclophosphamide
may prove effective; azathioprine is another possible
option. For relapses, combinations of the above can
be used.
Hypertension  is  treated  with  antihypertensive
agents, and aggressive therapy is necessary to pre-
vent complications. Antiplatelet agents and heparin
may prove useful in preventing stroke. 
Few procedures are necessary. Grafts have been
used to bypass regions of severe stenosis or occlu-
sion (23). Usually, the graft is a saphenous vein graft.
Extraintracranial bypass operations generally are
executed for stenosis of the internal carotid or mid-
dle  cerebral  arteries.  Percutaneous  transluminal
coronary angioplasty has been performed in a few
cases (32, 35). Information about outcome is, there-
fore, limited. Manfrini and Bugiardini
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TABLE I - ISHIKAWA’S CRITERIA FOR THE DIAGNOSIS OF TAKAYASU’S ARTERITIS (Ref. 2)
Criteria  Definition
Obligation criterion
Age < 40 year Age < 40 year at diagnosis or onset of characteristic signs and symptoms of 1 month 
duration in patient history
Two major criteria
1) Left mid subclavian artery The most severe stenosis or occlusion present in the mid portion from the point 1 cm 
proximal to the left vertebral artery orifice to that 3 cm distal to the orifice determined 
by angiography.
2) Right mid subclavian artery lesion The most severe stenosis or occlusion present in the mid portion from the right vertebral 
artery orifice to that 3 cm distal to the orifice determined by angiography.
Nine minor criteria
1) High ESR Unexplained persistent high ESR >20 mm/h (Westergreen) at diagnosis or presence 
of evidence in patient history.
2) Carotid artery tenderness  Unilateral or bilateral tenderness of common carotid arteries by physician palpation; 
neck muscle tenderness is unacceptable.
3) Hypertension  Persistent blood pressure > 140/90 mmHg brachial or >160/90 mmHg popliteal at age < 40 
year. Or presence of history at age < 40 year. 
4) Aotic regurgitation or annuloaortic ectasia By auscultation or Doppler echocardiography or angiography.
5) Pulmonary artery lesion  Lobar or segmental arterial occlusion or equivalent determined by angiography or 
perfusion scintigraphy, or presence of stenosis, aneurysm, luminal irregularity or any 
combination in pulmonary trunk or in unilateral or bilateral pulmonary arteries determined 
by angiography.
6) Left mid common carotid lesion Presence of most severe stenosis or occlusion in the mid portion of 5 cm in the length from 
the point 2 cm distal to its orifice determined by angiography.
7) Distal brachiocephalic trunk lesion Presence of most severe stenosis or occlusion in the distal third lesion determined by 
angiography
8) Descending thoracic aorta lesion Narrowing, dilatation or aneurysm, luminal irregularity or any lesion combination 
determined by angiography; tortuosity alone is unacceptable. 
9) Abdominal aorta lesion Narrowing, dilatation or aneurysm, luminal irregularity or any combination and absence of
lesion in aorto-iliac region consisting of 2 cm of termial aorta and bilateral common iliac 
arteries determnined by angiography; tortuosity alone is unacceptable.
The proposed criteria consist of one obligatory criterion, two major criteria, and nine minor criteria. In addition to the obligatory criterion,
the presence of major criteria, or of one major and two or more minor criteria or of four more minor criteria suggests a high probability of
the presence of Takayasu’s disease
TABLE II - CRITERIA OF AMERICAN COLLEGE OF RHEUMATOLOGY FOR THE CLASSIFICATION OF TAKAYASU’S ARTERITIS (Ref. 27)
Criteria  Definition
Age at disease onset in year Development of symptoms or findings related to Takayasu’s arteritis at age <40 years.
Claudication of extremities Development and worsening of fatigue and discomfort in muscles of one or more extremity 
while in use, especially the upper extremities. 
Decreased brachial artery pulse Decreased pulsation of one or both brachial arteries.
Blood pressure difference >10 mmHg Difference of >10 mmHg in systolic blood pressure between arms.
Bruit over subclavian arteries or aorta Bruit audible on auscultation over one or both subclavian arteries or abdominal aorta.
Arteriogram abnormality Arteriographic narrowing or occlusion of the entire aorta, its primary branches, or large 
arteries in the proximal upper or lower extremities, not due to arteriosclerosis, 
fibro-muscular dysplasia, or similar causes: changes usually focal or segmental.
For purposes of classification, a patient shall be said to have Takayasu’s arteritis if at least three of these six criteria are present. The pres-
ence of any three or more criteria yields a sensitivity of 90.5% and a specificity of 97.8%Takayasu’s arteritis
70
Focus on coronary arteries 
The incidence of coronary artery involvement has
been reported to be 9% to 10% (36). It is recognized
mainly at autopsy because angina pectoris is rarely a
presenting feature. It has been reported only in 6-16%
of cases (17, 37). Pathology often documents intimal fi-
brous thickening and typical atheromatous lesions. Ad-
vanced lesions demonstrate a panarteritis with intimal
proliferation. In these cases, prominent features are me-
dial smooth muscle and elastic lamina destruction, with
medial and adventitial cell infiltration and fibrosis (9).
Lesions produced by the inflammatory process can be
stenotic, occlusive, or aneurismal. Stenotic or occlusive
lesions are often located at the coronary ostia or at the
proximal segments of the arteries. Narrowing of the
coronary arteries is mainly due to the extension of the
inflammatory  processes  from  the  ascending  aorta.
Aneurysmal lesions may have areas of arterial narrow-
ing. Most of the coronary artery lesions in Takayasu’s
arteritis are stenotic or occlusive. Coronary aneurysms
seem to be very rare in Takayasu’s disease. Inflamma-
tion may diffusely involve the entire epicardial arterial
tree. Distinction of coronary narrowing due to athero-
sclerosis by narrowing due to focal coronary arteritis is
often difficult. Treatment of the coronary disease is still
problematic. Because Takayasu’s arteritis is rare, data
on mortality and morbidity are limited.
CONCLUSION
Takayasu’s arteritis should be considered in women
with a history of weakness, malaise, and fatigue. Thiscase
illustrates the consequences of a delayed diagnosis. 
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